Cordyceps Sunshine Biotech Holdings (RAJAF) Other Non-Current Liabilities (2022 - 2025)

Cordyceps Sunshine Biotech Holdings' Other Non-Current Liabilities history runs 4 years deep, the most recent figure standing at $240115.0 for Q4 2025.

• In Q4 2025, Other Non-Current Liabilities rose 140.18% year-over-year to $240115.0; the TTM figure through Dec 2025 stood at $240115.0 (up 140.18% YoY), while the FY2025 annual figure was $240115.0, up 140.18% from the prior year.
• Other Non-Current Liabilities was $240115.0 for Q4 2025 at Cordyceps Sunshine Biotech Holdings, up from $99975.0 in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $1.4 million in Q4 2022 to a low of $36302.0 in Q4 2023.
• Historically, Other Non-Current Liabilities has averaged $440724.0 across 4 years, with a median of $170045.0 in 2024.
• The sharpest annual moves came in 2023 and 2024: Other Non-Current Liabilities tumbled 97.38% in 2023, then jumped 175.4% in 2024.
• A 4-year view of Other Non-Current Liabilities shows it stood at $1.4 million in 2022, then sank by 97.38% to $36302.0 in 2023, then surged by 175.4% to $99975.0 in 2024, then soared by 140.18% to $240115.0 in 2025.
• The last three Other Non-Current Liabilities figures came in at $240115.0 (Q4 2025), $99975.0 (Q4 2024), and $36302.0 (Q4 2023), per Business Quant data.